These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6542601

  • 1. [Protective effect of a thromboxane synthetase inhibitor, OKY-046, in patients with acute respiratory failure].
    Sakio H, Usui Y, Mita H, Onoda N, Iida M, Okuda C.
    Masui; 1984 Sep; 33(9):964-9. PubMed ID: 6542601
    [No Abstract] [Full Text] [Related]

  • 2. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M, Ogawa K, Ito T, Chen LS, Ito Y, Imaizumi M, Uno T, Tsutsumi S, Satake T.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Sep; 13():375-7. PubMed ID: 3159226
    [No Abstract] [Full Text] [Related]

  • 3. Selective thromboxane synthetase inhibitor and ischemic heart disease.
    Ito T, Ogawa K, Watanabe J, Chen LS, Shikano M, Imaizumi M, Shibata T, Ito Y, Miyazaki Y, Satake T.
    Biomed Biochim Acta; 1984 Sep; 43(8-9):S125-32. PubMed ID: 6542777
    [No Abstract] [Full Text] [Related]

  • 4. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M.
    Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
    [No Abstract] [Full Text] [Related]

  • 5. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
    Yonekawa Y, Handa H, Okamoto S, Ohta T, Kamijo Y, Oda Y, Kondo A, Nin K, Yamamoto T, Ban S.
    Nihon Geka Hokan; 1986 May 01; 55(3):473-84. PubMed ID: 3541826
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T, Maeda K, Shibata M, Yamada K.
    Clin Nephrol; 1988 Nov 01; 30(5):276-81. PubMed ID: 3214971
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor].
    Okamoto S, Yonekawa Y, Handa H, Handa Y, Uemura Y, Yano I, Toyoshima M, Iwatsuji K, Teraura T, Yamagata S.
    Nihon Geka Hokan; 1986 Jan 01; 55(1):251-9. PubMed ID: 3741043
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T, Nomura T, Ozawa Y, Maeda K, Shibata M.
    Nihon Jinzo Gakkai Shi; 1987 Jun 01; 29(6):655-65. PubMed ID: 3682335
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
    Sakurai Y, Kagawa K, Kato Y, Otani H, Nonoyama A.
    Transplant Proc; 1990 Aug 01; 22(4):1686-8. PubMed ID: 2389433
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S, Wakitani K, Katsube N, Kawasaki A, Tsuboshima M, Naito J, Ujiie A, Komatsu H, Iizuka K.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Aug 01; 11():241-4. PubMed ID: 6221530
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs.
    Chung KF, Aizawa H, Becker AB, Frick O, Gold WM, Nadel JA.
    Am Rev Respir Dis; 1986 Aug 01; 134(2):258-61. PubMed ID: 3509981
    [Abstract] [Full Text] [Related]

  • 20. Prostacyclin and thromboxane in cerebral vasospasm II: Effects of thromboxane synthetase inhibitor (OKY-1581) on experimentally-induced cerebral vasospasm.
    Yabuno N.
    Acta Med Okayama; 1984 Jun 01; 38(3):239-50. PubMed ID: 6380217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.